Vivos Therapeutics, Inc. · NASDAQ:VVOS

V-CO Investors LLC reported a 9.90% stake in Vivos Therapeutics, Inc. (Schedule 13G)

Event Dec 17, 2024 · Filed Dec 20, 2024

V-CO Investors LLC reported a 9.90% stake in Vivos Therapeutics, Inc., 514,498 shares, as a passive investor on Dec 17, 2024. Filed Dec 20, 2024 (Schedule 13G).

Stake
9.90%
Shares
514,498
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
V-CO Investors LLC9.90%514,498
SP Manager LLC9.90%514,498
Michael Skaff9.90%514,498

Source

View original at SEC

Related